Congratulations to the entire Mirxes team!
Achieving a market capitalization exceeding USD 1 billion on the first day of trading on the Hong Kong Stock Exchange (HKEX) is a monumental milestone.
This accomplishment positions MiRXES as the region’s first biotech unicorn, setting a precedent for innovation and growth in ASEAN’s life sciences sector.
We are proud to be part of this success.
Here’s to scaling new heights, saving more lives, and shaping the future of precision medicine.
Looking forward to further our collaboration in Malaysia.
